<DOC>
	<DOCNO>NCT00451295</DOCNO>
	<brief_summary>This study consist 4 week run-in period Ca base phosphate binder 12 week treatment period MCI-196 placebo , ( Ca base phosphate binder ) . During treatment period , MCI-196 placebo titrate every 3 week .</brief_summary>
	<brief_title>A Phase III , Multi-Centre , Randomised , Placebo-Controlled Study Combination With Ca-based P Binders Patients With Hyperphosphatemia</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Hyperphosphatemia</mesh_term>
	<criteria>1 . Male female , 18 80 year age . 2 . Stable phosphate control use Calciumbased phosphatebinding medication . 3 . The subject undergoing regular dialysis treatment . 4 . On stabilised phosphorus diet . 5 . If female childbearing potential , negative serum pregnancy test . Sexually active female must agree take appropriate step become pregnant . 6 . Male subject must agree use appropriate contraception . 1 . Current clinically significant medical comorbidities , may substantially compromise subject safety , expose undue risk , interfere significantly study procedure , opinion Investigator , make subject unsuitable inclusion study . 2 . Body mass index ( BMI ) &lt; =16.0 kg/m2 = &gt; 40.0 kg/m2 . 3 . Current history significant gastrointestinal motility problem 4 . A positive test hepatitis B surface antigen , hepatitis C antibody HIV 1 2 antibody . 5 . A history substance alcohol abuse within last year . 6 . Seizure disorder . 7 . Using phosphate binder medication calcium base phosphate binder 8 . Using colestyramine , colestipol colesevelam 9 . A history drug allergy 10 . Participated clinical study experimental medication last 30 day experimental biological product within last 90 day , prior signing informed consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>Chronic Kidney Disease</keyword>
	<keyword>Dialysis</keyword>
	<keyword>Hyperphosphatemia</keyword>
</DOC>